Erratum: Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing (Proceedings of the National Academy of Sciences of the United States of America (2010) 107:35 (15373-15378) DOI: 10.1073/pnas.1009331107);Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 35, 2010, Pages 15373-15378

  Cho, Minseon ^a   Xiao, Yi ^a   Nie, Jeff ^b,c   Stewart, Ron ^b,c   Csordas, Andrew T ^d   Oh, Seung Soo ^a   Thomson, James A ^b,c   Soh, H Tom ^a  

^a University of California   (United States)

^b MORGRIDGE INSTITUTE FOR RESEARCH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

High throughput DNA sequencing; MicroMagnetic separation device; PDGF BB; Quantitative selection of aptamers through sequencing

Indexed keywords

APTAMER; PLATELET DERIVED GROWTH FACTOR BB;

ARTICLE; BINDING AFFINITY; DISSOCIATION CONSTANT; DNA SEQUENCE; FLUORESCENCE ANALYSIS; GENE DOSAGE; MICROFLUIDICS; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS;

EID: 77957259441     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1103208108     Document Type: Erratum

References (44)

1. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822.
2. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510. (Pubitemid 120031634)
3. Jayasena SD (1999) Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45:1628-2650.
4. Mairal T, et al. (2008) Aptamers: molecular tools for analytical applications. Anal Bioanal Chem 390:989-1007.
5. Huizenga DE, Szostak JW (1995) A DNA aptamer that binds adenosine and ATP. Biochemistry 34:656-665.
6. Mann D, Reinemann C, Stoltenburg R, Strehlitz B (2005) In vitro selection of DNA aptamers binding ethanolamine. Biochem Biophys Res Commun 338:1928-1934.
7. Bock LC, Griffin LC, Latham JA, Vermass EH, Toole JJ (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355:564-566.
8. Green LS, et al. (1996) Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 35:14413-14424. (Pubitemid 26384438)
9. Lupold SE, Hicke BJ, Lin Y, Coffey DS (2002) Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 62:4029-4033.
10. Mallikaratchy P, et al. (2007) Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics 6:2230-2238.
11. Xiao Y, Lubin AA, Heeger AJ, Plaxco KW (2005) Label-free electronic detection of thrombin in blood serum by using an aptamer-based sensor. Angew Chem Int Edit 44:5456-5459.
12. Swensen JS, et al. (2009) Continuous, real-time monitoring of cocaine in undiluted blood serum via a microfluidic, electrochemical aptamer-based sensor. J Am Chem Soc 131:4262-4266.
13. Chen HW, et al. (2008) Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem 3:991-1001.
14. Li W, et al. (2008) Real-time imaging of protein internalization using aptamer conjugates. Anal Chem 80:5002-5008. (Pubitemid 351956308)
15. McNamara JO, et al. (2008) Multivalent 4-1BB binding aptamers costimulate CD8 + T cells and inhibit tumor growth in mice. J Clin Invest 118:376-386.
16. Zhou J, Li H, Li S, Zaia J, Rossi JJ (2008) Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol Ther 16:1481-1489.
17. Tong GJ, Hsiao SC, Carrico ZM, Francis MB (2009) Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. J Am Chem Soc 131:11174-11178.
18. Tasset DM, Kubik MF, Steiner W(1997) Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J Mol Biol 272:688-698.
19. Lou X, et al. (2009) Micromagnetic selection of aptamers in microfluidic channels. Proc Natl Acad Sci USA 106:2989-2994.
20. Qian J, Lou X, Zhang Y, Xiao Y, Soh HT (2009) Generation of highly specific aptamers via micromagnetic selection. Anal Chem 81:5490-5495.
21. Tok JB, Fischer NO (2008) Single microbead SELEX for efficient ssDNA aptamer generation against botulinum neurotoxin. Chem Commun 1883-1885.
22. Wang J, Lv R, Xu D, Chen H (2008) Characterizing the interaction between aptamer and human IgE by use of surface plasmon resonance. Anal Bioanal Chem 390:1059-1065.
23. Chen CH, Chernis GA, Hoang VQ, Landgraf R (2003) Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proc Natl Acad Sci USA 100:9226-9231.
24. Lee JH, et al. (2005) A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci USA 102:18902-18907.
25. Stoltenburg R, Reinemann C, Strehlitz B (2005) FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal Bioanal Chem 383:83-91.
26. Djordjevic M (2007) SELEX experiments: new prospects, applications and data analysis in inferring regulatory pathways. Biomol Eng 24:179-189.
27. Stoltenburg R, Reinemann C, Strehlitz B (2007) SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 24:381-403.
28. Zimmermann B, Gesell T, Chen D, Lorenz C, Schroeder R (2010) Monitoring genomic sequences during SELEX using high-throughput sequencing: Neutral SELEX. PLoS One 5:e9169.
29. Alvarez RH, Kantarjian HM, Cortes JE (2006) Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 81:1241-1257. (Pubitemid 44316290)
30. Liu Y, et al. (2009) Controlling the selection stringency of phage display using a microfluidic device. Lab Chip 9:1033-1036.
31. Morozova O, Marra MA (2008) Applications of next-generation sequencing technologies in functional genomics. Genomics 92:255-264.
32. Mardis ER (2008) Next-generation DNA sequencing methods. Annu Rev Genom Hum G 9:387-402.
33. Acinas SG, Sarma-Rupavtarm R, Klepac-Ceraj V, Polz MF (2005) PCR-induced sequence artifacts and bias: Insights from comparison of two 16S rRNA clone libraries constructed from the same sample. Appl Environ Microbiol 71:8966-8969.
34. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415.
35. Luchansky SJ, Nolan SJ, Baranger AM (2000) Contribution of RNA conformation to the stability of a high-affinity RNA-protein complex. J Am Chem Soc 122:7130-7131.
36. Katilius E, Flores C, Woodbury NW (2007) Exploring the sequence space of a DNA aptamer using microarrays. Nucleic Acids Res 35:7626-7635.
37. Green L, et al. (1995) Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase. J Mol Biol 247:60-68.
38. Burgstaller P, Kochoyan M, Famulok M (1995) Structural probing and damage selection of citrulline and arginine-specific RNA aptamers identify base positions required for binding. Nucleic Acids Res 23:4769-4776.
39. Hoogenboom HR (2005) Selecting and screening recombinant antibody libraries. Nat Biotechnol 23:1105-1116.
40. Aina OH, et al. (2007) From combinatorial chemistry to cancer-targeting peptides. Mol Pharm 4:631-651.
41. Lee JS, Kim YK, Vendrell M, Chang YT (2009) Diversity-oriented fluorescence library approach for the discovery of sensors and probes. Mol Biosyst 5:411-421.
42. Silverman J, et al. (2005) Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains. Nat Biotechnol 23:1556-1561.
43. Puthenveetil S, et al. (2009) Yeast display evolution of a kinetically efficient 13-amino acid substrate for lipoic acid ligase. J Am Chem Soc 131:16430-16438.
44. Nutiu R, Li YF (2005) In vitro selection of structure-switching signaling aptamers. Angew Chem Int Edit 44:1061-1065.